M-L Lelez - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

M-L Lelez

Showing results (1-10 of 2) with videos related to

Pageof 1

Sort By:

Journal Francais D'Ophtalmologie|April 11, 2008

[Influence of the instillation of two versus three eyedrops of cyclopentolate 0.5% on refraction of Caucasian nonstrabismic children]F Gadioux-Madern, M-L Lelez, L Sellami, et al.

European Journal of Cancer (Oxford, England : 1990)|July 7, 2019

Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) networkC Soussain, S Choquet, M Blonski, et al.

Pageof 1

Search research articles

Showing results (1-10 of 2) with videos related to

Sort By:

Pageof 1

Journal Francais D'Ophtalmologie|April 11, 2008

[Influence of the instillation of two versus three eyedrops of cyclopentolate 0.5% on refraction of Caucasian nonstrabismic children]F Gadioux-Madern, M-L Lelez, L Sellami, et al.

European Journal of Cancer (Oxford, England : 1990)|July 7, 2019

Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) networkC Soussain, S Choquet, M Blonski, et al.

Pageof 1